GAD2

GAD2

GAD2 詳細

Molecule Name
Glutamate decarboxylase 2
分子の別称
GAD2,GAD65,Glutamate decarboxylase 2
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Pending
ターゲットの別称
EC 4.1.1.15,GAD65,Glutamate Decarboxylase 2 (Pancreatic Islets And Brain, 65kD),Glutamate Decarboxylase-2 (Pancreas),EC:4.1.1.15,EC 4.1.1,Glutamate decarboxylase 65 kDa isoform,65 kDa glutamic acid decarboxylase,GAD2,Glutamate Decarboxylase 2,Glutamate Decarboxylase 2 (Pancreatic Islets And Brain, 65kDa),GAD-65
バックグランド
Glutamate decarboxylase or glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the decarboxylation of glutamate to gamma-aminobutyric acid (GABA), the major inhibitory transmitter in higher brain regions, and putative paracrine hormone in pancreatic islets. GAD uses pyridoxal-phosphate (PLP) as a cofactor.Two molecular forms of GAD (65 kDa and 67 kDa) are highly conserved and both are expressed in the CNS, pancreatic islet cells, testis, oviduct and ovary. The isoforms are regionally distributed cytoplasmically in the brains of rats and mice. GAD65 is an ampiphilic, membrane-anchored protein (585 a.a.), and is responsible for vesicular GABA production. GAD67 is cytoplasmic (594 a.a.), and seems to be responsible for significant cytoplasmic GABA production.

GAD2 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
KLS-2031KLS-2031Kolon Life Science. Inc
詳細